Explore CrownBio's virtual American Diabetes Association 2020 event to catch up with the latest preclinical research on diabetes, NAFLD/NASH, obesity, cardiovascular and renal diseases.
Archive for: CrownBio
Dr. Thomas Scullion discusses how to leverage NHP exploratory toxicology studies to guide and explore lead optimization, dosing paradigms, and future GLP studies.
Leigh Goedeke, PhD reviews spontaneous nonhuman primate (NHP) models of NAFLD and metabolic syndrome as a more clinically-relevant preclinical study platform.
Andrew Puca, PhD discusses techniques for optimizing preclinical diabetes research in spontaneously diabetic NHPs, with a focus on stress free assessments of glucose measurement and response using continuous glucose monitoring and the banana tolerance test.